Dabiclot 110 Capsule
Prescription Required
10 Capsule
Manufacturer
Alkem Laboratories LtdSalt Composition
Dabigatran etexilate (110Mg)Storage
Store below 30°C
- It prevents blood clot.
- It prevents deep vein thrombosis.
- It prevents pulmonary embolism.
- Details
- Benefits
Dabiclot 110 Capsule are one of a group of medicines called anticoagulants or blood thinners, which are used to treat and lower the risk of heart attack and stroke by preventing blood clotting. Additionally, it is used to lessen the risk of clots in patients who have undergone knee or hip replacement surgery, as well as to prevent deep vein thrombosis (blood clots in the leg veins), pulmonary embolism (blood clots in the lungs), and other blood clot-related conditions.
Usage instructions-
- Read the pack carefully and use as directed by your doctor.
How it works-
A new oral anticoagulant (NOAC) is Dabiclot 110 Capsule. It functions by stopping the body from developing blood clots.
Safety information-
Pregnancy
It is recommended to consult your doctor before taking it during pregnancy.
Breastfeeding
Avoid this medication during breastfeeding or use it after consulting your doctor.
Alcohol
It is unknown whether it is safe or not to take Alcohol with this medication.
Driving
It is unknown whether it is safe or not to drive with this medication. If you have faces any symptoms, don't drive.
Kidney
It is advised to consult your doctor before taking this medicine if you have any kidney issue.
Liver
If you have any concerns about using this medicine in patients with liver impairment, please consult your doctor.
- The medicine class known as anticoagulants, or blood thinners, includes Dabiclot 110 Capsule.
- By lowering blood clot formation, Dabiclot 110 Capsule is mainly used to treat and lower the risk of stroke and heart attack.
- In addition to this, it lessens the chance of clot development in patients who have had knee or hip replacement surgery.
- Thrombin, also known as clotting factor 10, is what Dabiclot 110 Capsule does its work.
- Blood clotting is avoided because it avoids the transformation of fibrinogen, a soluble protein, into fibrin, an insoluble protein.




